D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 2, 2006, Pages 830-834

  Clément, Pierre ^a   Bernabé, Jacques ^a   Kia, Hosein Kami ^a   Alexandre, Laurent ^a   Giuliano, François ^a,b  

^a CNRS   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; QUINELORANE; RACLOPRIDE; SEROTONIN 1A ANTAGONIST; SPIPERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BULBOSPONGIOSUS MUSCLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; EJACULATION; MALE; MUSCLE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPERM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EJACULATION; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SEROTONIN AGONISTS;

EID: 31144450687     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.092411     Document Type: Article

References (37)

1. Ahlenius S and Larsson K (1987) Evidence for a unique pharmacological profile of 8-OH-DPAT by evaluation of its effects on male rat sexual behavior, in Brain 5-HT1A Receptors: Behavioral and Neurochemical Pharmacology (Dourish CT, Ahlenius S, and Hutson PH eds) pp 185-198, Ellis Horwood, Chichester, UK.
2. Ahlenius S and Larsson K (1989) Antagonism by pindolol, but not betaxolol, of 8-OH-DPAT-induced facilitation of male rat sexual behavior. J Neural Transm 77:163-170.
3. Ahlenius S, Larsson K, and Svensson L (1980) Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior. Psychopharmacology 68:217-220.
4. Ahlenius S, Larsson K, and Wijkstrom A (1991) Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. Eur J Pharmacol 200:259-266.
5. Andersen PH, Gronvald FC, and Jansen JA (1985) A comparison between dopaminestimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum. Life Sci 37:1971-1983.
6. Bitran D, Thompson JT, Hull EM, and Sachs BD (1989) Quinelorane (LY163502), a D2 dopamine receptor agonist, facilitates seminal emission, but inhibits penile erection in the rat. Pharmacol Biochem Behav 34:453-458.
7. (2)O: the pressure at the urinary bladder neck during human ejaculation. Prostate 44:339-341.
8. Chivers JK, Gommeren W, Leysen JE, Jenner P, and Marsden CD (1988) Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. J Pharm Pharmacol 40:415-421.
9. Fernandez-Guasti A and Escalante A (1991) Role of presynaptic serotonergic receptors on the mechanism of action of 5-HT1A and 5-HT1B agonists on masculine sexual behaviour: physiological and pharmacological implications. J Neural Transm Gen Sect 85:95-107.
10. Fernandez-Guasti A, Escalante AL, Ahlenius S, Hillegaart V, and Larsson K (1992) Stimulation of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual behaviour. Eur J Pharmacol 210:121-129.
11. Fernandez-Guasti A and Rodriguez-Manzo G (1997) 8-OH-DPAT and male rat sexual behavior: partial blockade by noradrenergic lesion and sexual exhaustion. Pharmacol Biochem Behav 56:111-116.
12. Foreman MM and Hall JL (1987) Effects of D2-dopaminergic receptor stimulation on male rat sexual behavior. J Neural Transm 68:153-170.
13. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, and Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81-88.
14. Fuller RW and Mason NR (1986) Flumezapine, an antagonist of central dopamine and serotonin receptors. Res Commun Chem Pathol Pharmacol 54:23-34.
15. Gerstenberg TC, Levin RJ, and Wagner G (1990) Erection and ejaculation in man: assessment of the electromyographic activity of the bulbocavernosus and ischiocavernosus muscles. Br J Urol 65:395-402.
16. Gil-Vernet JM Jr, Alvarez-Vijande R, Gil-Vernet A, and Gil-Vernet JM (1994) Ejaculation in men: a dynamic endorectal ultrasonographical study. Br J Urol 73:442-448.
17. Giuliano F and Clément P (2005) Physiology of ejaculation: emphasis on serotonergic control. Eur Urol 48:408-417.
18. 3H]raclopride to rat and human brain membranes. J Neurochem 55:2048-2057.
19. Harik SI, Sromek SM, and Kalaria RN (1991) Alpha- and beta-adrenergic receptors of the rat cerebral cortex and cerebral microvessels in aging and their response to denervation. Neurobiol Aging 12:567-573.
20. Hillegaart V, Ahlenius S, and Larsson K (1991) Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT. Behav Brain Res 42:169-180.
21. Holmes GM, Chapple WD, Leipheimer RE, and Sachs BD (1991) Electromyographic analysis of the male rat perineal muscles during copulation and reflexive erections. Physiol Behav 49:1235-1246.
22. Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8:59-81.
23. Hull EM, Warner RK, Bazzett TJ, Eaton RC, Thompson JT, and Scaletta LL (1989) D2/D1 ratio in the medial preoptic area affects copulation of male rats. J Pharmacol Exp Ther 251:422-427.
24. Johansson L, Sohn D, Thorberg S-O, Jackson DM, Kelder D, Larsson L-G, Rényi L, Ross SB, Wallsten C, Eriksson H, et al. (1997) The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 283:216-225.
25. Kung MP, Frederick D, Mu M, Zhuang ZP, and Kung HF (1995) 4-(2′-Methoxyphenyl)-1-[2′-(n″-2-pyridinyl)-p-iodobenzamido] -ethyl-piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. J Pharmacol Exp Ther 272:429-437.
26. 3H-ligand for serotonin2 receptor binding sites: binding properties, brain distribution and functional role. Mol Pharmacol 21:301-314.
27. Master VA and Turek PJ (2001) Ejaculatory physiology and dysfunction. Urol Clin North Am 28:363-375.
28. Matuszewich L, Lorrain DS, Trujillo R, Dominguez J, Putnam SK, and Hull EM (1999) Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist. Brain Res 820:55-62.
29. McKenna KE, Chung SK, and McVary KT (1991) A model for the study of sexual function in anesthetized male and female rats. Am J Physiol 261:R1276-R1285.
30. Newman H, Reiss H, and Northurp JD (1982) Physical basis of emission, ejaculation and orgasm in the male. Urology 19:341-350.
31. Paxinos G and Watson C (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
32. Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47:529-540.
33. Peroutka SJ and Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic and histamine receptors to clinical potency. Am J Psychiatry 137:1518-1522.
34. Pfaus JG and Phillips AG (1991) Role of dopamine in anticipatory and consummatory aspects of sexual behavior in the male rat. Behav Neurosci 105:727-743.
35. Smith CF and Cutts S (1990) Dopamine agonist activity of 8-OH-DPAT. Arch Int Pharmacodyn Ther 306:106-113.
36. Sokoloff P, Giros B, Martres MP, Bouthenet ML, and Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (Lond) 347:146-151.
37. Van Wijngaarden I, Tulp MT, and Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 188:301-312.